Jiangsu Hanbon Science and Technology Investor Relations
Jiangsu Hanbon Science and Technology Earnings Call Summary
Earnings Call Summary
A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
Jiangsu Hanbon Science and Technology Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About Jiangsu Hanbon Science and Technology Co., Ltd.
J
J
Jiangsu Hanbon Science and Technology Co., Ltd.
688755
Jiangsu Hanbon Science and Technology Co., Ltd. engages in the research and development, production, and sale of liquid chromatography products in China and internationally. It offers biopharm purification equipment, including chromatography column products, chromatography systems, buffer dilution/conditioning systems, filtration systems, and single-use systems; bio-oligo synthesizer products, such as nucleic acid synthesizer and oligonucleotide synthesis column products; and preparative liquid chromatography system and chromatographic column products. The company also provides continuous chromatographic systems comprising simulated moving bed and continuous Ion exchange chromatography products; and supercritical fluid chromatography products, including analytical supercritical fluid chromatography, SFC-dynamic axial compression column, and CO2 booster station products. In addition, it offers biopharmaceutical purification, cell and gene therapy purification, and small molecule purification solutions. The company was founded in 1998 and is based in Huai'an, China.
Jiangsu Hanbon Science and Technology Co., Ltd. engages in the research and development, production, and sale of liquid chromatography products in China and internationally. It offers biopharm purification equipment, including chromatography column products, chromatog...
Jiangsu Hanbon Science and Technology Co., Ltd. engages in the research and development, production, and sale of liquid chromatography products in China and internationally. It offers biopharm purification equipment, including chromatography column products, chromatography systems, buffer dilution/conditioning systems, filtration systems, and single-use systems; bio-oligo synthesizer products, such as nucleic acid synthesizer and oligonucleotide synthesis column products; and preparative liquid chromatography system and chromatographic column products. The company also provides continuous chromatographic systems comprising simulated moving bed and continuous Ion exchange chromatography products; and supercritical fluid chromatography products, including analytical supercritical fluid chromatography, SFC-dynamic axial compression column, and CO2 booster station products. In addition, it offers biopharmaceutical purification, cell and gene therapy purification, and small molecule purification solutions. The company was founded in 1998 and is based in Huai'an, China.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.